GlobeNewswire

Hitachi Aims To Disrupt Industrial IoT Platform Market With New Commercial Lumada Software Stack

Dela

Fully Enhanced and Now Available as a Standalone Offering for IoT Developers and Architects, Hitachi's Lumada Provides an Intelligent, Composable Platform That Delivers Faster Time to Insight and Business Value for Industrial and Enterprise Customers

TOKYO and LAS VEGAS, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Hitachi Ltd. (TSE:6501) and Hitachi Vantara, today jointly announced Hitachi's first commercial Lumada internet of things (IoT) platform offering. Now in its v2.0 release, the Lumada IoT platform has been fully updated with an elegant, portable architecture that enables it to run both on-premises or in the cloud and to support industrial IoT deployments both at the edge and in the core.

The new software stack is designed to help customers quickly and easily gain insights, predictions and recommendations from their data, and can be easily adapted to support mid-to-large-scale environments. Lumada's integrated advanced analytics have also been enhanced with artificial intelligence (AI) functionality at scale. The result is a highly intelligent and flexible platform that accelerates superior outcomes for enterprise and industrial customers, such as increased operational efficiencies and cost savings, enhanced operational safety and reliability, improved asset utilization, performance management and product quality, and the creation of new business models.

Among the notable advancements to the Lumada IoT platform are asset avatars, Hitachi's unique approach to what is commonly referred to as "digital twins." Asset avatars provide a digital representation of physical assets and rich metadata for analytics, serving as a digital proxy for business and industrial assets and providing rapid data-driven insights into their health and performance, with continuously updated sensor values. This approach helps to eliminate "blind spots" in operation-critical systems by providing improved access to - and insights from - business, machine and human data, which can help users move more rapidly from measurement to management to improvement. The newly enhanced software stack also provides IoT developers and architects with powerful design tools and features that simplify the creation and deployment industrial IoT solutions, with faster time to insight.

Since introducing Lumada to the market as a co-creation platform in May 2016, Hitachi has hardened and optimized its Lumada IoT platform. These improvements are based on numerous deployments in proof-of concept (POC) and co-creation project engagements with its customers and partners, as well as in its own factories.

Hitachi worked with customer Daicel Corporation to co-create an image analysis system using Lumada that improves product quality and increases productivity by detecting signs of facility failures and deviations in front-line worker motions. This system has allowed Daicel to improve the in-process guarantee rate for products.

Another customer, Okuma Corporation, worked with Hitachi to co-create an advanced high-efficiency production model with Hitachi to support mass customization in its manufacturing plants. The target of this joint demonstration experiment is to double productivity and reduce production lead time by 50%. 

Based on the best practices developed throughout projects like these, Hitachi has enhanced Lumada's functionality to simplify management of business and industrial assets, support greater asset utilization and accelerate the time to value of IoT deployments. Its next generation architecture is highly flexible, composable and adaptable to support customers' existing business and IT environments and help them to more rapidly achieve highly optimized outcomes.

Customers looking to accelerate their IoT initiatives using Lumada will benefit from engaging Hitachi's co-creation services, tapping its expansive expertise in both operation technology (OT) and information technology (IT) to create customized IoT solutions that are tailored to their unique requirements.

"Our next-generation Lumada IoT platform demonstrates Hitachi's unparalleled expertise in both OT and IT, and reinforces Hitachi's commitment to being an innovation partner for our customers in the IoT era," said Keiji Kojima, chairman at Hitachi Vantara and senior vice-president and executive officer at Hitachi Ltd. "With the powerful advancements delivered today, our customers and partners can now choose to harness the full power of Lumada's AI, advanced analytics and asset avatars capabilities to simplify their own IoT solution development or to accelerate their digital transformation initiatives in co-creation projects with Hitachi. In either case, we believe Hitachi is delivering a highly intelligent and unique solution that challenges the industrial IoT platform market status quo." 

Hitachi's next-generation Lumada IoT platform architecture has been fully updated with five major layers to form a flexible, portable and composable software foundation with comprehensive security capabilities and expanded support for unstructured data uploads. IoT developers and architects will also benefit from Lumada's dynamic design features, rich analytics and robust asset management capabilities, including:

  • Lumada edge: Allows any variety and velocity of data to be easily ingested, transformed and analyzed in close proximity to physical assets.
  • Lumada core: Provides asset registry, identity and access management and simplifies the creation of asset avatars.
  • Lumada analytics: Blends OT and IT data to uncover patterns with powerful analytics, machine learning and AI.
  • Lumada studio: Delivers predefined widgets to simplify the creation of dashboard applications; issues alerts, notifications or just straight-through processing.
  • Lumada  foundry: Offers foundational services to ease deployment on-premises and in the cloud, as well as security, microservices and support features.

"We are exceedingly proud of the next-generation Lumada software stack we are delivering to the market and opening up to developers today," said Rich Rogers, senior vice-president of engineering and product management at Hitachi Vantara. "However, Hitachi's intention is that Lumada will be much more than just another IoT platform in a crowded market. Lumada's ultimate purpose is to make it simple to harness the power of IoT data to drive real value for Hitachi's customers and partners. We remain committed to delivering exceptional integrated software, solutions and services for Lumada. Our vision is that one day all Hitachi machines will be connected to it, enriching the data-driven insights and value we can provide to ensure every Hitachi customer will benefit."

Product Availability and Information
Hitachi's Lumada IoT platform software is generally available now for purchase and in co-creation engagements with Hitachi and select partners. Some features may not be immediately available in all markets. For more information and a complete list of product and feature enhancements, visit https://www.hitachivantara.com/en-us/products/internet-of-things/lumada.html.  

Experience Hitachi's Lumada IoT Platform at NEXT 2017
Hitachi's new Lumada IoT platform software and related solutions will be on display at the company's user conference, Hitachi NEXT, in Las Vegas, September 19 and 20, 2017. Event attendees can see live demonstrations of the software and the innovative IoT solutions Hitachi and its customers and partners are developing with it.

The event also features a full track of IoT developer breakout sessions, providing attendees with an opportunity to engage directly with Hitachi product management executives and development teams. The developer breakout session will provide a deep dive on the latest architectural advancements, design features and best practices for building industrial and commercial enterprise IoT solutions with Lumada. For more information, visit www.hitachinext.com

About Hitachi Vantara
Hitachi Vantara, a wholly owned subsidiary of Hitachi, Ltd., helps data-driven leaders find and use the value in their data to innovate intelligently and reach outcomes that matter for business and society. We combine technology, intellectual property and industry knowledge to deliver data-managing solutions that help enterprises improve their customers' experiences, develop new revenue streams, and lower the costs of business. Only Hitachi Vantara elevates your innovation advantage by combining deep information technology (IT), operational technology (OT) and domain expertise. We work with organizations everywhere to drive data to meaningful outcomes. Visit us at HitachiNewCo.com. Visit us at www.HitachiVantara.com.

Connect With Hitachi Vantara

About Hitachi, Ltd.
Hitachi, Ltd. (TSE:6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges. The company's consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in Social Innovation and has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information, please visit http://www.hitachi.com.

HITACHI is a trademark or registered trademark of Hitachi, Ltd. All other trademarks, service marks, and company names are properties of their respective owners.

COMPANY CONTACTS
Hope Nicora
Hitachi Vantara
Hope.Nicora@hitachivantara.com
+1 831-227-3660




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hitachi Vantara via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum